Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.71

+0.4%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wgmnoris who wrote (1517)	8/31/2000 12:14:07 PM
From: Biomaven	Read Replies (2) of 52153

DNAP They don't appear to be a SEC reporting company. Means you can't necessarily trust their numbers, and one is left to rely on P&D'ers for one's information. They intend to be the leaders (and I think they currently are) in doing sophisticated DATA MINING of the Genome data that recently was completed. This is ridiculous. Celera with a billion dollars in cash looking for useful employment is likely to end up as the bioinformatics leader. Not to mention some light-weight competitors like INCY and RSTA. <g> Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next